BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6770974)

  • 1. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
    Hahn TJ; Halstead LR; Strates B; Imbimbo B; Baran DT
    Calcif Tissue Int; 1980; 31(2):109-15. PubMed ID: 6770974
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: a comparison with prednisone.
    Caniggia A; Marchetti M; Gennari C; Vattimo A; Nicolis FB
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):126-34. PubMed ID: 66216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
    Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
    Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha-hydroxychloecalciferol treatment of long-term hemodialyzed patients. Effects on mineral metabolism, bone mineral content and bone morphometry.
    Nielsen HE; Melsen F; Christensen MS; Hansen HE; Rodbro P; Johannsen A
    Clin Nephrol; 1977 Oct; 8(4):429-34. PubMed ID: 923161
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
    Gennari C; Imbimbo B; Montagnani M; Bernini M; Nardi P; Avioli LV
    Calcif Tissue Int; 1984 May; 36(3):245-52. PubMed ID: 6432287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral and bone metabolism in thyroid disease: a review.
    Auwerx J; Bouillon R
    Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA; Lloyd HM
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of prolonged bed rest on bone mineral.
    Donaldson CL; Hulley SB; Vogel JM; Hattner RS; Bayers JH; McMillan DE
    Metabolism; 1970 Dec; 19(12):1071-84. PubMed ID: 4321644
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone and mineral metabolism in adult celiac disease.
    Caraceni MP; Molteni N; Bardella MT; Ortolani S; Nogara A; Bianchi PA
    Am J Gastroenterol; 1988 Mar; 83(3):274-7. PubMed ID: 3257843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineralization and bone mineral content in primary hyperparathyroidism.
    Tougaard L; Hau C; Rodbro P; Ditzel J
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):314-9. PubMed ID: 576347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of phosphate and thyrocalcitonin on skeletal turnover.
    Haddad JG; Avioli LV
    Endocrinology; 1970 Dec; 87(6):1245-50. PubMed ID: 5482702
    [No Abstract]   [Full Text] [Related]  

  • 13. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis.
    Leboff MS; Wade JP; Mackowiak S; el-Hajj Fuleihan G; Zangari M; Liang MH
    J Rheumatol; 1991 Mar; 18(3):339-44. PubMed ID: 1856804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dialysis prescription on bone and mineral metabolism: the National Cooperative Dialysis Study.
    Harter HR; Laird NM; Teehan BP
    Kidney Int Suppl; 1983 Apr; (13):S73-9. PubMed ID: 6345900
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prednisone on growth and bone mineral content in childhood glomerular disease.
    Chesney RW; Mazess RB; Rose P; Jax DK
    Am J Dis Child; 1978 Aug; 132(8):768-72. PubMed ID: 685891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dissociation of the effects of PTH on bone matrix and calcium in rats.
    Kalu DN; Hadji-Georgopoulos A; Foster GV
    Horm Metab Res; 1975 Sep; 7(5):443-4. PubMed ID: 1183927
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
    Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
    Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypervitaminosis A on the bone and mineral metabolism of the rat.
    Hough S; Avioli LV; Muir H; Gelderblom D; Jenkins G; Kurasi H; Slatopolsky E; Bergfeld MA; Teitelbaum SL
    Endocrinology; 1988 Jun; 122(6):2933-9. PubMed ID: 3371268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.